 | Merrimack Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 11:08 PM |
 | Merrimack Pharmaceuticals: SCLC Presents A Lower Hurdle For Approval Than Initially Assumed
seekingalpha.com - April 14 at 5:51 PM |
| Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update
finance.yahoo.com - April 2 at 4:41 PM |
 | Merrimack Pharmaceuticals Inc.
www.barrons.com - February 24 at 12:01 AM |
| Merrimack Pharmaceuticals - A Better Way To Invest In Biotechnology
seekingalpha.com - February 20 at 12:55 PM |
| What Kind Of Share Price Volatility Should You Expect For Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK)?
finance.yahoo.com - February 7 at 2:33 PM |
| Hedge Funds Are Selling Merrimack Pharmaceuticals Inc (MACK)
finance.yahoo.com - December 22 at 11:30 PM |
| Merrimack Pharmaceuticals declares $0.50 dividend
seekingalpha.com - December 3 at 2:43 PM |
| Merrimack Pharma up 6% on $6.7M special dividend
seekingalpha.com - December 3 at 2:43 PM |
| Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan
finance.yahoo.com - December 3 at 2:43 PM |
|
| Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend
finance.yahoo.com - December 3 at 8:49 AM |
 | Knee Bursitis Treatment Market 2019 Research and Development- Novartis, Pfizer, Merck, Amgen, Bayer, AVEO Pharmaceuticals
www.marketwatch.com - November 30 at 7:49 AM |
 | Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says
www.bizjournals.com - October 28 at 9:05 AM |
| Merrimack Pharmaceuticals Offers Significant And Uncorrelated Upside Potential
seekingalpha.com - October 1 at 7:16 AM |
 | BRIEF-JFL Capital Ends Campaign At Merrimack
www.msn.com - September 24 at 9:20 PM |
| JFL Capital Ends Campaign at Merrimack
finance.yahoo.com - September 24 at 9:20 PM |
| Concert Pharmaceuticals Names Jeffrey Munsie as Chief Legal Officer
www.marketwatch.com - September 23 at 3:57 PM |
| BRIEF-Merrimack Pharmaceuticals Says Co Enters Into Cooperation Agreement With Newtyn Management And Western Standard
www.msn.com - September 20 at 2:52 PM |
| Merrimack Pharmaceuticals Announces Changes to Board of Directors
finance.yahoo.com - September 20 at 2:52 PM |
| Should You Buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) For This Reason?
finance.yahoo.com - September 20 at 2:52 PM |
| Merrimack to pay $20M cash dividend today
seekingalpha.com - September 5 at 5:13 PM |
 | Merrimack Pharmaceuticals Announces Per Share Amount for Previously Declared Special Dividend
www.nasdaq.com - September 5 at 5:13 PM |
| BRIEF-Merrimack - JFL Capital Management Has Launched "Unnecessary" Proxy Contest To Replace Entire Board, Effectively Seeking To Acquire Co
www.msn.com - August 27 at 8:35 AM |
| Merrimack Pharmaceuticals Issues Letter to Shareholders
finance.yahoo.com - August 26 at 7:44 PM |
| Texas investor group fighting for control of crumbling Merrimack Pharmaceuticals
finance.yahoo.com - August 26 at 7:44 PM |
| BRIEF-JFL Capital Issues Letter To Fellow Merrimack Stockholders
www.msn.com - August 22 at 11:10 PM |
| JFL Capital Issues Letter to Fellow Merrimack Stockholders
finance.yahoo.com - August 22 at 9:28 AM |
| BRIEF-Merrimack Pharmaceuticals Reschedules Annual Meeting Of Shareholders
www.msn.com - August 17 at 12:09 AM |
|
| BRIEF-Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting Of Shareholders For October 17
www.msn.com - August 17 at 12:09 AM |
 | Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019
www.businesswire.com - August 16 at 9:46 AM |
| Anaplastic Astrocytoma Drug Market Scope by Trends and Opportunities to Expand Significantly by 2026
www.marketwatch.com - August 12 at 11:35 PM |
| Merrimack Pharmaceuticals declares $1.50 dividend
seekingalpha.com - July 25 at 10:01 AM |
| Merrimack Declares $20 Million Special Dividend
finance.yahoo.com - July 25 at 10:01 AM |
 | The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering
www.benzinga.com - May 31 at 8:23 AM |
| Merrimack axes remaining staff, execs after selling assets to New York startup
www.bizjournals.com - May 31 at 8:23 AM |
| Merrimack -2.6% as it decides against sale
seekingalpha.com - May 30 at 6:42 PM |
| Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend
finance.yahoo.com - May 30 at 6:42 PM |
 | Merrimack Reports First Quarter 2019 Financial Results
www.prnewswire.com - May 10 at 7:59 AM |
| COMM 2014-UBS2 Mortgage Trust -- Moody's affirms ten classes of COMM 2014-UBS2
finance.yahoo.com - May 3 at 7:14 PM |
| Merrimack to cut headcount after MM-310 flop
seekingalpha.com - April 30 at 6:52 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merrimack Pharmaceuticals, Inc. - MACK
finance.yahoo.com - April 9 at 10:15 PM |
| Merrimack Pharmaceuticals, Inc. (MACK) - Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation
finance.yahoo.com - April 8 at 7:50 PM |
 | Merrimack Discontinues Cancer Study Amidst Layoffs
247wallst.com - April 5 at 7:49 PM |
| TrovaGene leads healthcare gainers; Merrimack Pharmaceuticals and Syros Pharmaceuticals among losers
seekingalpha.com - April 5 at 12:25 PM |
| The Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Is Down 92% So Some Shareholders Are Rather Upset
finance.yahoo.com - April 5 at 10:42 AM |
| Merrimack bails on lead candidate; shares down 9% after hours
seekingalpha.com - April 4 at 8:04 PM |
| Merrimack Discontinues Development of MM-310
finance.yahoo.com - April 4 at 8:04 PM |
| Merrimack shelves another cancer drug, plans more layoffs
finance.yahoo.com - April 4 at 8:04 PM |
| Merrimack Pharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 20 at 10:47 PM |
| Merrimack Reports Fourth Quarter and Full Year 2018 Financial Results - PRNewswire
www.prnewswire.com - March 7 at 8:33 AM |
